8 October 2013 in Immunology & Cell Biology
GFGeorgina Filio‐Rodríguez
NMNicholas Avrion Mitchison
Nicholas Avrion Mitchison
EVErnesto Antonio Vázquez‐Sánchez
Ernesto Antonio Vázquez‐Sánchez
+3
8 December 2015 in Aging Clinical and Experimental Research
TPThalía Gabriela Pérez-Suárez
Thalía Gabriela Pérez-Suárez
+5
1 January 2014 in International Journal of Genomics
Background.Leprosy is a chronic infectious disease caused by the intracellular acid-fast bacilliMycobacterium leprae; it has been determined that genetic factors of the host play an important role in the disease susceptibility. Thus, in this case-control study, we evaluated the possible association between theIL-17A G-197A(rs227593) andIL-17F A7488G(His161Arg, rs763780) gene SNPs and susceptibility to leprosy disease in Mexican population.Methods.Seventy-five leprosy patients and sixty-nine control subjects were included. Both SNPs were genotyped with the polymerase chain reaction-restriction fragment length polymorphism technique.Results.We found nonsignificant differences in genotype and allele frequencies related toIL-17A G-197A(rs227593) andIL-17F A7488G(His161Arg, rs763780) gene SNPs in MB as well as subclinical forms of leprosy disease versus healthy individuals.Conclusions.Since the sample size is not large enough, it is difficult to sustain an association of susceptibility to leprosy with genotypes or allele frequencies ofIL-17A G-197A(rs227593) andIL-17F A7488G(His161Arg, rs763780), suggesting thatIL-17polymorphisms have no significant role in the genetic susceptibility to development of this disease in the Mexican Mestizo population.
27 December 2016 in Annals of Human Genetics
LFLuis Octavio Frías‐Castro
Luis Octavio Frías‐Castro
GRGeovanni Romero‐Quintana
+6
7 January 2019 in Biomedical Reports
NTNora Magdalena Torres‑Carrillo
Nora Magdalena Torres‑Carrillo
MGMaricela García‑Lechuga
+6
Leprosy, a human chronic granulomatous disease caused by Mycobacterium leprae (M. leprae), remains endemic in certain countries despite the use of multidrug therapy. Recently, several host genes modulating the immune responses to M. leprae infection have been suggested to influence the acquisition and clinical course of leprosy. Lymphoid protein tyrosine phosphatase, encoded by the protein tyrosine phosphatase non‑receptor type 22 (PTPN22) gene, serves a negative regulatory role in T cell activation. The non‑synonymous single‑nucleotide polymorphism (SNP) rs2476601 (1858C>T) has been associated with autoimmune diseases. Here, the present study investigated if rs2476601 polymorphism was associated with leprosy in a Mexican mestizo population. Genotyping was performed in patients with leprosy (n=189) and control subjects (n=231) from regions with higher incidence of leprosy. Genotypic (P=0.44) and allelic frequencies (P=0.45) of the rs2476601 polymorphism were similar between patients and controls; genotypic frequencies were 91 vs. 94% for CC and 9 vs. 6% for CT, and the TT genotype was absent in both groups. Allelic frequencies were 96 vs. 97% for C, and 4 vs. 3% for T. In the same way, the genotypic (P=0.46) and allelic frequencies (P=0.47) from MB patients and controls were similar. In conclusion, there was a lack of association of the PTPN22 rs2476601 polymorphism with the development of leprosy, which suggests that this SNP was not a genetic risk factor for leprosy in the Mexican mestizo population studied.